Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Huang

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2006
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysisDavid B Huang, James P Nataro, Herbert L DuPont, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureusDavid B Huang, Eric Gaukel, Nancy Kerzee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
The role of diet in the treatment of travelers' diarrhea: a pilot studyDavid B Huang, Mukta Awasthi, Binh-Minh Le, et al.
Expert Opinion on Emerging Drugs|December 2, 2004
Emerging therapies for herpes viral infections (types 1 - 8)Arun Chakrabarty, Katie R Pang, Jashin J Wu, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
Journal of Clinical Microbiology|November 10, 2006
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countriesJamal A Mohamed, David B Huang, Zhi-Dong Jiang, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 8, 2010
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trialsBenjamin A Lipsky, Kamal M F Itani, John A Weigelt, et al.
Diagnostic Microbiology and Infectious Disease|September 30, 2018
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and EuropeDavid B Huang, Sophie Magnet, Stefania De Angelis, et al.
Journal of Medical Microbiology|March 20, 2008
Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot studyDavid B Huang, Eric L Brown, Herbert L DuPont, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2006
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysisDavid B Huang, James P Nataro, Herbert L DuPont, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureusDavid B Huang, Eric Gaukel, Nancy Kerzee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
The role of diet in the treatment of travelers' diarrhea: a pilot studyDavid B Huang, Mukta Awasthi, Binh-Minh Le, et al.
Expert Opinion on Emerging Drugs|December 2, 2004
Emerging therapies for herpes viral infections (types 1 - 8)Arun Chakrabarty, Katie R Pang, Jashin J Wu, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
Journal of Clinical Microbiology|November 10, 2006
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countriesJamal A Mohamed, David B Huang, Zhi-Dong Jiang, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 8, 2010
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trialsBenjamin A Lipsky, Kamal M F Itani, John A Weigelt, et al.
Diagnostic Microbiology and Infectious Disease|September 30, 2018
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and EuropeDavid B Huang, Sophie Magnet, Stefania De Angelis, et al.
Journal of Medical Microbiology|March 20, 2008
Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot studyDavid B Huang, Eric L Brown, Herbert L DuPont, et al.
Pageof 9